other · Figshare
Abstract Background Anterior Open Bite (AOB) is a complex malocclusion with esthetic, functional, and psychosocial implications, highlighting the need for early diagnosis and interceptive treatment. Objective To compare the effectiveness of bonded Tongue Spurs combined with a Low Trans Palatal Arch (TS/LTPA) versus bonded Tongue Spurs (TS) alone in managing AOB associated with tongue habit during the mixed dentition stage. Materials and methods Fifty children were assessed for eligibility; 32 were randomized, and 30 completed the 6-month follow-up and were included in the final analysis. They aged 7 to 11 years (10 boys, 20 girls) in the mixed dentition phase, having a dentoskeletal AOB of at least 1 mm, an Angle Class I molar relationship, and CMI stages 2 and 3. TS/LTPA group comprised 16 patients (7 males and 9 females) exhibiting bonded lingual tongue spurs and a low transpalatal arch. TS group included 14 patients (3 males and 11 females) who had bondable lingual tongue spurs only. The mean age was 8.73 ± 1.00 years in the TS/LTPA group and 9.03 ± 0.68 years in the TS group. Digital lateral cephalograms and models were obtained prior to and six months post-treatment. Results Both groups (TS/LTPA and TS) showed improvement in overbite closure, with a median change of + 2.97 mm (IQR 1.16 to 5.00; p < .001) in the TS/LTPA group and + 3.67 mm (IQR 2.00 to 5.00; p = .001) in the TS group, respectively. However, the difference between groups was not statistically significant. A statistically significant vertical molar control was observed in the TS/LTPA group (+ 0.40 mm, IQR 0.30 to 0.65; p = .001) compared to the TS group (+ 0.90 mm, IQR 0.70 to 1.00; p = .001), with significant differences between both groups. Conclusion Both TS/LTPA and TS groups showed a reduction in overbite, along with incisor extrusion and retroclination. The TS/LTPA group provided significantly better vertical molar control than the TS group; however, the difference in AOB closure between the groups was not statistically significant. Trial registration This single-center randomized controlled trial received ethical approval from Alexandria University’s Research Ethics Committee, Alexandria, Egypt (IORG0008839, No. 0313 − 10/2021). This trial was retrospectively registered in the Pan African Clinical Trial Registry (PACTR202403582913859) on 14 March 2024.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.6084/m9.figshare.c.8328938
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.